
OBJECTIVES Mental health (MH) diagnoses can complicate outcomes of underlying medical conditions. However, prevalence of MH diagnoses across the spectrum of complex and/or chronic conditions is poorly understood. We aimed to (1) compare prevalence of MH diagnoses across categories of complex and chronic conditions and (2) identify factors associated with MH diagnoses among children with noncomplex chronic conditions (NCCCs) and complex chronic conditions (CCCs). METHODS Retrospective cross-sectional study of 2.9 million children aged 5 to 17 years from MarketScan Medicaid Database representing 12 US states in 2022. The primary exposure was mutually exclusive categories of complex and chronic conditions: noncomplex nonchronic (NCNC) conditions, NCCCs, and CCCs. The outcome was presence of a mood or anxiety MH diagnosis (anxiety, depression, bipolar disorder, obsessive-compulsive disorders, trauma-related disorders, and suicide/self-injury) coded at 1 inpatient/emergency department or 2 outpatient encounters. RESULTS Prevalence of MH diagnoses increased with increasing medical complexity and chronicity: 7.6% in NCNC, 16.0% in NCCCs, and 20.0% in CCCs (P < .001). Among children with a CCC, categories with the greatest adjusted odds of MH diagnoses were cardiac (odds ratio [OR] 1.49; 95% CI, 1.44–1.54), neurologic (OR 1.18; 95% CI, 1.14–1.23), and renal (OR 1.13; 95% CI, 1.06–1.21). Among youth with NCCCs or CCCs, Black and Hispanic children had lower odds of MH diagnoses compared to non-Hispanic white children. CONCLUSIONS MH prevalence increased significantly with increasing medical complexity and chronicity. Differences in MH diagnoses were identified across individual NCCC and CCC categories and sociodemographic characteristics. These results may inform future screening, intervention, and health equity efforts among medically vulnerable populations.
Human parainfluenza viruses (PIVs) caused an estimated 18.8 million acute lower respiratory infection episodes, 725 000 hospitalizations, and 34 400 deaths among children under 5 in 2018, ranking second only to respiratory syncytial virus (RSV). Despite this burden, clinical attention has historically focused on croup, leading to the common perception that parainfluenza is a single disease entity. However, the 4 types differ substantially in taxonomy, tropism, clinical syndrome, and severity. PIV-1, the most common cause of croup, drives biennial epidemics in toddlers, whereas PIV-2 is less frequent but can cause severe disease, particularly in children with underlying conditions. PIV-3 predominates in young infants, causing bronchiolitis and pneumonia clinically like RSV infection, reflecting its early postnatal susceptibility, which may relate to earlier and more frequent viral exposure. PIV-4, historically underrecognized due to culture limitations, usually does not cause croup but is linked to lower respiratory tract disease, hypoxemia, and occasional neurologic complications. PIV infections are most severe in infants, immunocompromised children, and those in low-resource settings. Seasonal patterns vary by type and geography. Advances in multiplex molecular diagnostics now allow rapid type-specific detection, improving clinical interpretation and management. No vaccine or antiviral is licensed. Emerging therapeutics include sialidase-based antivirals with Food and Drug Administration Breakthrough designation; monoclonal antibodies capable of cross-neutralizing PIV-1, PIV-3, RSV, and human metapneumovirus; and messenger RNA vaccines showing early immunogenicity in children. Recognizing the distinct epidemiology, clinical features, and immune responses of each type is critical for informed pediatric care and the development of targeted preventive and therapeutic strategies.
The work of pediatrician Barbara Starfield established that primary care is unique. Defined by first-contact access, continuity, comprehensiveness, and coordination—and delivered through enduring relationships with patients and families—primary care provides the essential foundation for any high-performing health care system. Yet the United States has persistently underinvested in that foundation, leaving primary care practices chronically under resourced.1 Recognizing this crisis for the overall population, states and national organizations are measuring primary care spending, setting explicit investment targets, and pressing to rebalance the health care dollar toward primary care. Although these approaches differ in payer scope, definitions, and enforcement, they share a central premise: within a constrained health care budget, greater investment in primary care must be intentional rather than left to market forces. One recent expression of this movement, the Triple Double campaign, calls for doubling primary care investment from 5% to 10% of health care spending, while also doubling its reach and the proportion of the next generation choosing primary care.2 In this issue of Pediatrics, Perrin et al ask an essential question that this movement has largely left unanswered: What should primary care investment policy mean for children?3